Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-4-11
pubmed:abstractText
Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1) initiates generation of amyloid beta (Abeta), a pathological hallmark of Alzheimer's disease. We investigated the impact of BACE1 protein level on endogenous Abeta. Endogenous Abeta and BACE1 protein levels were concurrently and significantly reduced during early life. However, Abeta levels were similar between BACE1 transgenic and wildtype mice. This suggests that BACE1 protein level has a minimal effect on the level of endogenous Abeta. Consequently, other factors must be involved in modulation of Abeta production in adult and ageing brain and investigation of such factors may yield therapeutic targets. Further, these results suggest that substantial inhibition of BACE1 in brain may be required for clinical benefit in Alzheimer's disease.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-11224536, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-12112088, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-12130773, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-12223024, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-12514700, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-12670422, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-1402883, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-14715132, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-15509532, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-15689559, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-15987683, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-16221845, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-16332141, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-16354928, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-16990514, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-17083447, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-17099708, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-17409228, http://linkedlifedata.com/resource/pubmed/commentcorrection/18343582-17616527
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0304-3940
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
435
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo.
pubmed:affiliation
Department of Neurology, Georgetown University Medical Center, Washington, DC 20057, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural